Obio Technology (Shanghai) Corp., Ltd. (SHA:688238)
China flag China · Delayed Price · Currency is CNY
7.99
-0.08 (-0.99%)
Aug 21, 2025, 4:00 PM EDT

Obio Technology (Shanghai) Corp. Company Description

Obio Technology (Shanghai) Corp., Ltd., a biotechnology company, focuses on the development of gene therapy vectors in China.

The company provides gene function and gene therapy research, and other CRO services, such as drug target and drug efficacy research.

It also offers CDMO services, such as process development and testing, IND-CMC pharmaceutical research, and clinical sample GMP production for the research and development of genetic drugs.

The company was founded in 2013 and is headquartered in Shanghai, China.

Obio Technology (Shanghai) Corp., Ltd.
CountryChina
Founded2013
IndustryBiotechnology
SectorHealthcare
Employees692
CEOOudong Pan

Contact Details

Address:
Building 19
Shanghai, 201321
China
Phone86 21 5858 5887
Websiteobiosh.com

Stock Details

Ticker Symbol688238
ExchangeShanghai Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
SIC Code8731

Key Executives

NamePosition
Oudong PanFounder, Chairman of the Board and GM
Luyuan XuDeputy GM, Chief Financial Officer, Accounting Supervisor and Board Secretary
Junyi PanInvestment Director, GM of Regenerative Medicine Division and Director
Fujie WangVice President of Supply Chain and Information Technology and Director
Shan YinDeputy GM and Director
Qingmei XiaDeputy General Manager
Qinbin WuDeputy General Manager
Xinglin YangR and D Director
Jiali YangDeputy Director of Research & Development
Houliang WeiVice President of Process Development